(Q39720186)

14 September 2017

title

Blocking EGFR in the liver improves the tumor-to-liver uptake ratio of radiolabeled EGF. (English)

1 reference

14 September 2017

Heewa Kareem

1

1 reference

14 September 2017

Karl Sandström

2

1 reference

14 September 2017

Ronny Elia

3

1 reference

14 September 2017

Lars Gedda

4

1 reference

14 September 2017

Matti Anniko

5

1 reference

14 September 2017

Hans Lundqvist

6

1 reference

14 September 2017

Marika Nestor

7

1 reference

14 September 2017

publication date

30 January 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

31

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

79-87

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-009-0011-2

14 September 2017

exact match

0 references

cites work

Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amount

1 reference

12 December 2020

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

1 reference

12 December 2020

Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture

1 reference

12 December 2020

Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF.

1 reference

12 December 2020

The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels.

1 reference

12 December 2020

Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy

1 reference

12 December 2020

Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma

1 reference

12 December 2020

Biodistribution of 111in-DTPA-D-Phe1-octreotide in tumor-bearing nude mice: influence of amount injected and route of administration

1 reference

12 December 2020

TP53 mutations and survival in squamous-cell carcinoma of the head and neck.

1 reference

12 December 2020

Quantification of CD44v6 and EGFR expression in head and neck squamous cell carcinomas using a single-dose radioimmunoassay

1 reference

12 December 2020

Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck

1 reference

12 December 2020

EGFR and cancer prognosis

1 reference

12 December 2020

The head and neck surgeon as oncologist

1 reference

12 December 2020

Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line

1 reference

12 December 2020

Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer

1 reference

12 December 2020

Epidemiology of head and neck cancer: magnitude of the problem

1 reference

12 December 2020

Pharmacological background of EGFR targeting

1 reference

12 December 2020

Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats.

1 reference

12 December 2020

Untangling the ErbB signalling network

1 reference

12 December 2020

Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression

1 reference

12 December 2020

Variations of EGF-R surface expression in squamous cell carcinomas of the head and neck region

1 reference

12 December 2020

Affibody molecules: new protein domains for molecular imaging and targeted tumor therapy

1 reference

12 December 2020

Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule

1 reference

12 December 2020

Effects of HER2-binding affibody molecules on intracellular signaling pathways

1 reference

12 December 2020

Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry

1 reference

12 December 2020

Epidermal growth factor and the kidney

1 reference

12 December 2020

Molecular pathology of head-and-neck cancer

1 reference

12 December 2020

Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount

1 reference

12 December 2020

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

1 reference

12 December 2020

Recurrent squamous-cell carcinoma of the head and neck: overview of current therapy and future prospects

1 reference

12 December 2020

10.1007/S13277-009-0011-2

Identifiers

DOI

1 reference

14 September 2017

1 reference